Nabriva Therapeutics PLC (NASDAQ:NBRV)

0.835
Delayed Data
As of 12:59pm ET
 -0.0147 / -1.73%
Today’s Change
0.81
Today|||52-Week Range
4.58
-65.50%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Nabriva Therapeutics PLC have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +379.04% increase from the last price of 0.84.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Nabriva Therapeutics PLC. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.21
Sales
$9.9M
Reporting Date
Mar 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.00%
 
 
 
 
 
 
Growthannually 79.30%
 
 
 
 
 
 

Sales

Growthquarterly 11.15%
 
 
 
 
 
 
Growthannually 486.51%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.